tDCS trial for musculoskeletal and spinal cord diseases

Transcranial direct current stimulation for musculoskeletal and spinal cord diseases

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs032180298

Enrollment

160

Registered

2019-03-15

Start date

2013-04-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy, Cervical spondylotic amyotrophy, Lumbar spinal canal stenosis, Rota Cervical spondylotic myelopathy, Cervical spondylotic amyotrophy, Lumbar spinal canal stenosis, Rotator cuff tear, Frozen shoulder

Interventions

Transcranial Direct Current Stimulation (tDCS)

E02.331.750

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Participants who can be obtained informed consent from themselves 2)Currently, taking no medical treatment for serious health reasons such as mental and neurological diseases. 3)Health subjects or Patients with cervical spondylotic myelopathy, cervical spondylotic amyotrophy, lumbar spinal canal stenosis, rotator cuff tear, or frozen shoulder 4)Dominant hand or foot is the right 5)No contraindication on the implementation of transcranial magnetic stimulation (TMS) or tDCS

Exclusion criteria

Exclusion criteria: 1)Patients with complication of more than one disease which is cervical spondylotic myelopathy, cervical spondylotic amyotrophy, lumbar spinal canal stenosis, rotator cuff tear, or frozen shoulder 2)Patients with obvious resting pain 3)Suspected women who are pregnancy 4)Complete paralysis 5)Participants who have any contraindications on the implementation of TMS or TMS 6)Participants who have any contraindications for undergoing an MRI scan 7)Participants who are judged unsuitable subjects by a doctor

Design outcomes

Primary

Measure	Time frame
Apply following evaluations before and after tDCS using t-test or ANOVA in each group 1)Sensory evaluations: VAS, Perception and pain quantitative analysis device 2)Motor functional evaluations : Muscle strength, Dexterity, balancing and walking capability 3)Cortical excitability(single pulse TMS): Measurements of Motor Evoked Potentials	—

Secondary

Measure	Time frame
1) Comparison of brain activities between tDCS group of each disease and control group 2) Multiple comparison test is performed for each voxel for each individual in fMRI, and the results are used to analyze by t-test or ANOVA in each group.	—

Contacts

Public ContactHitoshi Shitara

Gunma University Hospital

hshitara@gunma-u.ac.jp+81-27-220-8269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026